ARTICLE | Company News
ScinoPharm, Foresee forming JV for controlled-release injectables
January 31, 2013 2:08 AM UTC
API manufacturer ScinoPharm Taiwan Ltd. (Tainan, Taiwan) and drug delivery company Foresee Pharmaceuticals Inc. (Newark, Del.) will form a JV to develop peptide injectable drugs for cancer. ScinoPharm will provide its API manufacturing capabilities, while Foresee will contribute its controlled-release delivery technology to the JV. ScinoPharm will invest $3.6 million for a minority stake in the JV. The companies could not be reached for details. ...